HEADER OXIDOREDUCTASE 11-FEB-21 7NI1 TITLE CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD TITLE 2 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYELOPEROXIDASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 167-271; COMPND 5 SYNONYM: MPO; COMPND 6 EC: 1.11.2.2; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: MYELOPEROXIDASE; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: UNP RESIDUES 279-744; COMPND 11 SYNONYM: MPO; COMPND 12 EC: 1.11.2.2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: HL60; SOURCE 6 CELL: NEUTROPHILS; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 CELL_LINE: HL60; SOURCE 12 CELL: NEUTROPHILS KEYWDS OXIDOREDUCTASE, COMPLEX, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR T.SJOGREN,T.INGHARDT REVDAT 6 31-JAN-24 7NI1 1 REMARK REVDAT 5 21-SEP-22 7NI1 1 JRNL REVDAT 4 07-SEP-22 7NI1 1 JRNL REVDAT 3 31-AUG-22 7NI1 1 JRNL REVDAT 2 20-APR-22 7NI1 1 JRNL REVDAT 1 23-FEB-22 7NI1 0 JRNL AUTH T.INGHARDT,T.ANTONSSON,C.ERICSSON,D.HOVDAL,P.JOHANNESSON, JRNL AUTH 2 C.JOHANSSON,U.JURVA,J.KAJANUS,B.KULL,E.MICHAELSSON, JRNL AUTH 3 A.PETTERSEN,T.SJOGREN,H.SORENSEN,K.WESTERLUND,E.L.LINDSTEDT JRNL TITL DISCOVERY OF AZD4831, A MECHANISM-BASED IRREVERSIBLE JRNL TITL 2 INHIBITOR OF MYELOPEROXIDASE, AS A POTENTIAL TREATMENT FOR JRNL TITL 3 HEART FAILURE WITH PRESERVED EJECTION FRACTION. JRNL REF J.MED.CHEM. V. 65 11485 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36005476 JRNL DOI 10.1021/ACS.JMEDCHEM.1C02141 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 73796 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 3581 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.12 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.76 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1476 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2481 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1406 REMARK 3 BIN R VALUE (WORKING SET) : 0.2473 REMARK 3 BIN FREE R VALUE : 0.2647 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.74 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9109 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 345 REMARK 3 SOLVENT ATOMS : 643 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.01240 REMARK 3 B22 (A**2) : 3.92690 REMARK 3 B33 (A**2) : 6.08550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.13840 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.300 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.260 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.201 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.253 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.200 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.875 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.840 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 9720 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 13253 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3395 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1675 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 9720 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1259 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 11886 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.25 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.19 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7NI1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1292113979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 1.1.7 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73815 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 48.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.55200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.080 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1CXP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 3350, 100 MM NACL, PROTEIN REMARK 280 BUFFER CONTAINED 50 MM AMMOIUM SULPHATE, 20 MM AMMONIUM ACETATE REMARK 280 PH 5.5 AND 2 MM CACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.91000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -112.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -96.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 105 REMARK 465 ALA B 104 REMARK 465 ALA B 105 REMARK 465 VAL C 113 REMARK 465 ALA C 578 REMARK 465 VAL D 113 REMARK 465 ALA D 578 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 20 0.38 -69.08 REMARK 500 SER A 42 -40.13 -151.86 REMARK 500 GLU B 3 -8.84 -57.34 REMARK 500 PRO B 20 0.45 -69.51 REMARK 500 SER B 42 -39.13 -151.81 REMARK 500 ARG C 136 -54.99 -126.23 REMARK 500 LEU C 310 70.02 -118.63 REMARK 500 ARG C 314 -61.07 -104.44 REMARK 500 GLN C 396 54.37 -141.48 REMARK 500 ASN C 457 95.99 -160.53 REMARK 500 ASN C 555 3.36 -155.29 REMARK 500 ARG D 136 -54.81 -126.49 REMARK 500 ASN D 225 99.56 -160.61 REMARK 500 LEU D 310 70.17 -118.87 REMARK 500 ARG D 314 -61.91 -103.30 REMARK 500 GLN D 396 53.82 -141.81 REMARK 500 LYS D 488 18.79 59.91 REMARK 500 ASN D 555 2.26 -154.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D 918 DISTANCE = 7.61 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BMA C 607 REMARK 610 BMA D 601 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA C 601 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 96 O REMARK 620 2 ASP A 96 OD1 70.1 REMARK 620 3 THR C 168 O 77.9 147.3 REMARK 620 4 THR C 168 OG1 139.9 138.6 72.3 REMARK 620 5 PHE C 170 O 102.6 79.7 101.8 109.2 REMARK 620 6 ASP C 172 OD1 140.8 71.3 141.2 72.0 76.3 REMARK 620 7 SER C 174 OG 84.1 74.7 108.7 80.8 149.5 79.9 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 203 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 336 NE2 REMARK 620 2 HEM A 203 NA 104.3 REMARK 620 3 HEM A 203 NB 95.9 87.7 REMARK 620 4 HEM A 203 NC 87.0 168.6 89.2 REMARK 620 5 HEM A 203 ND 103.9 91.7 159.7 87.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D 605 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 96 O REMARK 620 2 ASP B 96 OD1 75.1 REMARK 620 3 THR D 168 O 75.9 150.0 REMARK 620 4 THR D 168 OG1 133.5 142.4 66.7 REMARK 620 5 PHE D 170 O 108.7 83.0 98.8 103.6 REMARK 620 6 ASP D 172 OD1 150.9 77.4 132.4 68.4 77.0 REMARK 620 7 SER D 174 OG 86.6 81.9 104.3 77.3 154.9 80.2 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 203 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 336 NE2 REMARK 620 2 HEM B 203 NA 103.0 REMARK 620 3 HEM B 203 NB 97.1 87.1 REMARK 620 4 HEM B 203 NC 89.3 167.4 89.0 REMARK 620 5 HEM B 203 ND 102.0 91.0 160.7 88.7 REMARK 620 N 1 2 3 4 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 167 TO 270 REMARK 999 RESIDUES 279 TO 744 DBREF 7NI1 A 1 105 UNP P05164 PERM_HUMAN 167 271 DBREF 7NI1 B 1 105 UNP P05164 PERM_HUMAN 167 271 DBREF 7NI1 C 113 578 UNP P05164 PERM_HUMAN 279 744 DBREF 7NI1 D 113 578 UNP P05164 PERM_HUMAN 279 744 SEQRES 1 A 105 CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR GLY MET SEQRES 2 A 105 CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SER ASN SEQRES 3 A 105 ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR GLU ASP SEQRES 4 A 105 GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY VAL LYS SEQRES 5 A 105 ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA VAL SER SEQRES 6 A 105 ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU THR PRO SEQRES 7 A 105 ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP GLY GLN SEQRES 8 A 105 LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU PRO ALA SEQRES 9 A 105 ALA SEQRES 1 B 105 CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR GLY MET SEQRES 2 B 105 CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SER ASN SEQRES 3 B 105 ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR GLU ASP SEQRES 4 B 105 GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY VAL LYS SEQRES 5 B 105 ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA VAL SER SEQRES 6 B 105 ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU THR PRO SEQRES 7 B 105 ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP GLY GLN SEQRES 8 B 105 LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU PRO ALA SEQRES 9 B 105 ALA SEQRES 1 C 466 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 C 466 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 C 466 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CSO PRO SEQRES 4 C 466 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 C 466 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 C 466 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 C 466 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 C 466 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 C 466 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 C 466 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 C 466 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 C 466 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 C 466 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 C 466 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 C 466 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 C 466 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 C 466 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 C 466 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 C 466 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 C 466 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 C 466 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 C 466 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 C 466 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 C 466 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 C 466 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 C 466 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 C 466 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 C 466 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 C 466 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 C 466 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 C 466 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 C 466 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 C 466 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 C 466 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 C 466 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 C 466 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA SEQRES 1 D 466 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 D 466 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 D 466 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CSO PRO SEQRES 4 D 466 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 D 466 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 D 466 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 D 466 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 D 466 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 D 466 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 D 466 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 D 466 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 D 466 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 D 466 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 D 466 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 D 466 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 D 466 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 D 466 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 D 466 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 D 466 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 D 466 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 D 466 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 D 466 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 D 466 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 D 466 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 D 466 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 D 466 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 D 466 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 D 466 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 D 466 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 D 466 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 D 466 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 D 466 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 D 466 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 D 466 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 D 466 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 D 466 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA MODRES 7NI1 CSO C 150 CYS MODIFIED RESIDUE MODRES 7NI1 CSO D 150 CYS MODIFIED RESIDUE HET CSO C 150 7 HET CSO D 150 7 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET FUC E 5 10 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET FUC F 5 10 HET CL A 201 1 HET CL A 202 1 HET HEM A 203 43 HET CL B 201 1 HET CL B 202 1 HET HEM B 203 43 HET CA C 601 1 HET CL C 602 1 HET CL C 603 1 HET NAG C 604 14 HET NAG C 605 14 HET UEB C 606 26 HET BMA C 607 11 HET BMA D 601 11 HET CL D 602 1 HET NAG D 603 14 HET NAG D 604 14 HET CA D 605 1 HET UEB D 606 26 HETNAM CSO S-HYDROXYCYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CA CALCIUM ION HETNAM UEB (S)-1-(2-(AMINO(PHENYL)METHYL)BENZYL)-2-THIOXO-1,2,3,5- HETNAM 2 UEB TETRAHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN HEM HEME HETSYN UEB 1-[[2-[(~{R})-AZANYL(PHENYL)METHYL]PHENYL]METHYL]-2- HETSYN 2 UEB SULFANYLIDENE-5~{H}-PYRROLO[3,2-D]PYRIMIDIN-4-ONE FORMUL 3 CSO 2(C3 H7 N O3 S) FORMUL 5 NAG 8(C8 H15 N O6) FORMUL 5 BMA 4(C6 H12 O6) FORMUL 5 MAN 2(C6 H12 O6) FORMUL 5 FUC 2(C6 H12 O5) FORMUL 7 CL 7(CL 1-) FORMUL 9 HEM 2(C34 H32 FE N4 O4) FORMUL 13 CA 2(CA 2+) FORMUL 18 UEB 2(C20 H18 N4 O S) FORMUL 26 HOH *643(H2 O) HELIX 1 AA1 LEU A 60 VAL A 69 1 10 HELIX 2 AA2 PRO A 72 LEU A 76 5 5 HELIX 3 AA3 LEU A 84 ASP A 98 1 15 HELIX 4 AA4 LEU B 60 VAL B 69 1 10 HELIX 5 AA5 PRO B 72 LEU B 76 5 5 HELIX 6 AA6 LEU B 84 ASP B 98 1 15 HELIX 7 AA7 ALA C 173 GLY C 178 1 6 HELIX 8 AA8 GLU C 180 LEU C 187 1 8 HELIX 9 AA9 PRO C 220 ASN C 225 1 6 HELIX 10 AB1 MET C 243 ASN C 268 1 26 HELIX 11 AB2 ASP C 272 ASP C 295 1 24 HELIX 12 AB3 TYR C 296 LEU C 310 1 15 HELIX 13 AB4 ALA C 325 PHE C 332 1 8 HELIX 14 AB5 ARG C 333 ILE C 339 5 7 HELIX 15 AB6 SER C 362 VAL C 364 5 3 HELIX 16 AB7 SER C 368 GLU C 374 1 7 HELIX 17 AB8 ILE C 377 THR C 387 1 11 HELIX 18 AB9 VAL C 399 GLU C 404 1 6 HELIX 19 AC1 ASP C 416 HIS C 428 1 13 HELIX 20 AC2 GLY C 432 CYS C 440 1 9 HELIX 21 AC3 THR C 447 ARG C 456 1 10 HELIX 22 AC4 ASN C 457 GLY C 469 1 13 HELIX 23 AC5 THR C 470 ILE C 474 5 5 HELIX 24 AC6 ASP C 475 GLU C 483 1 9 HELIX 25 AC7 GLY C 492 GLY C 509 1 18 HELIX 26 AC8 SER C 521 ALA C 529 1 9 HELIX 27 AC9 SER C 532 THR C 541 1 10 HELIX 28 AD1 SER C 565 LEU C 567 5 3 HELIX 29 AD2 LEU C 572 ARG C 576 5 5 HELIX 30 AD3 ALA D 173 GLY D 178 1 6 HELIX 31 AD4 GLU D 180 LEU D 187 1 8 HELIX 32 AD5 PRO D 220 ASN D 225 5 6 HELIX 33 AD6 MET D 243 ASN D 268 1 26 HELIX 34 AD7 ASP D 272 ASP D 295 1 24 HELIX 35 AD8 TYR D 296 LEU D 310 1 15 HELIX 36 AD9 ALA D 325 PHE D 332 1 8 HELIX 37 AE1 ARG D 333 ILE D 339 5 7 HELIX 38 AE2 SER D 362 VAL D 364 5 3 HELIX 39 AE3 ALA D 367 GLU D 374 1 8 HELIX 40 AE4 ILE D 377 THR D 387 1 11 HELIX 41 AE5 VAL D 399 GLU D 404 1 6 HELIX 42 AE6 PHE D 407 MET D 411 5 5 HELIX 43 AE7 ASP D 416 HIS D 428 1 13 HELIX 44 AE8 GLY D 432 CYS D 440 1 9 HELIX 45 AE9 THR D 447 ARG D 456 1 10 HELIX 46 AF1 ASN D 457 GLY D 469 1 13 HELIX 47 AF2 THR D 470 ILE D 474 5 5 HELIX 48 AF3 ASP D 475 GLU D 483 1 9 HELIX 49 AF4 GLY D 492 GLY D 509 1 18 HELIX 50 AF5 SER D 521 ALA D 529 1 9 HELIX 51 AF6 SER D 532 THR D 541 1 10 HELIX 52 AF7 SER D 565 LEU D 567 5 3 HELIX 53 AF8 LEU D 572 ARG D 576 5 5 SHEET 1 AA1 2 ARG A 27 ALA A 28 0 SHEET 2 AA1 2 ILE C 164 ASN C 165 -1 O ASN C 165 N ARG A 27 SHEET 1 AA2 2 PRO A 78 SER A 83 0 SHEET 2 AA2 2 PRO C 388 LYS C 390 -1 O ALA C 389 N ASP A 79 SHEET 1 AA3 2 ARG B 27 ALA B 28 0 SHEET 2 AA3 2 ILE D 164 ASN D 165 -1 O ASN D 165 N ARG B 27 SHEET 1 AA4 2 PRO B 78 SER B 83 0 SHEET 2 AA4 2 PRO D 388 LYS D 390 -1 O ALA D 389 N ASP B 79 SHEET 1 AA5 2 LEU C 128 LYS C 129 0 SHEET 2 AA5 2 CYS C 143 ILE C 144 -1 O ILE C 144 N LEU C 128 SHEET 1 AA6 2 PHE C 342 PHE C 344 0 SHEET 2 AA6 2 ARG C 358 PRO C 360 -1 O VAL C 359 N MET C 343 SHEET 1 AA7 2 THR C 545 SER C 547 0 SHEET 2 AA7 2 PHE C 561 ASN C 563 -1 O VAL C 562 N VAL C 546 SHEET 1 AA8 2 LEU D 128 LYS D 129 0 SHEET 2 AA8 2 CYS D 143 ILE D 144 -1 O ILE D 144 N LEU D 128 SHEET 1 AA9 2 PHE D 342 PHE D 344 0 SHEET 2 AA9 2 ARG D 358 PRO D 360 -1 O VAL D 359 N MET D 343 SHEET 1 AB1 2 THR D 545 SER D 547 0 SHEET 2 AB1 2 PHE D 561 ASN D 563 -1 O VAL D 562 N VAL D 546 SSBOND 1 CYS A 1 CYS A 14 1555 1555 2.03 SSBOND 2 CYS B 1 CYS B 14 1555 1555 2.04 SSBOND 3 CYS C 115 CYS C 125 1555 1555 2.04 SSBOND 4 CYS C 119 CYS C 143 1555 1555 2.06 SSBOND 5 CYS C 153 CYS D 153 1555 1555 2.04 SSBOND 6 CYS C 221 CYS C 232 1555 1555 2.04 SSBOND 7 CYS C 440 CYS C 497 1555 1555 2.06 SSBOND 8 CYS C 538 CYS C 564 1555 1555 2.03 SSBOND 9 CYS D 115 CYS D 125 1555 1555 2.03 SSBOND 10 CYS D 119 CYS D 143 1555 1555 2.04 SSBOND 11 CYS D 221 CYS D 232 1555 1555 2.03 SSBOND 12 CYS D 440 CYS D 497 1555 1555 2.04 SSBOND 13 CYS D 538 CYS D 564 1555 1555 2.04 LINK OD2 ASP A 94 CMD HEM A 203 1555 1555 1.47 LINK CMB HEM A 203 OE2 GLU C 242 1555 1555 1.45 LINK CBB HEM A 203 SD MET C 243 1555 1555 1.84 LINK OD2 ASP B 94 CMD HEM B 203 1555 1555 1.48 LINK CMB HEM B 203 OE2 GLU D 242 1555 1555 1.43 LINK CBB HEM B 203 SD MET D 243 1555 1555 1.78 LINK C SER C 149 N CSO C 150 1555 1555 1.35 LINK C CSO C 150 N PRO C 151 1555 1555 1.34 LINK ND2 ASN C 189 C1 NAG C 604 1555 1555 1.44 LINK ND2 ASN C 225 C1 NAG C 605 1555 1555 1.43 LINK ND2 ASN C 317 C1 NAG E 1 1555 1555 1.43 LINK C SER D 149 N CSO D 150 1555 1555 1.36 LINK C CSO D 150 N PRO D 151 1555 1555 1.34 LINK ND2 ASN D 189 C1 NAG D 603 1555 1555 1.44 LINK ND2 ASN D 225 C1 NAG D 604 1555 1555 1.43 LINK ND2 ASN D 317 C1 NAG F 1 1555 1555 1.43 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.40 LINK O6 NAG E 1 C1 FUC E 5 1555 1555 1.40 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.42 LINK O3 BMA E 3 C1 MAN E 4 1555 1555 1.43 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.40 LINK O6 NAG F 1 C1 FUC F 5 1555 1555 1.40 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.42 LINK O3 BMA F 3 C1 MAN F 4 1555 1555 1.43 LINK O ASP A 96 CA CA C 601 1555 1555 2.23 LINK OD1 ASP A 96 CA CA C 601 1555 1555 2.69 LINK FE HEM A 203 NE2 HIS C 336 1555 1555 2.12 LINK O ASP B 96 CA CA D 605 1555 1555 2.19 LINK OD1 ASP B 96 CA CA D 605 1555 1555 2.31 LINK FE HEM B 203 NE2 HIS D 336 1555 1555 2.13 LINK O THR C 168 CA CA C 601 1555 1555 2.28 LINK OG1 THR C 168 CA CA C 601 1555 1555 2.34 LINK O PHE C 170 CA CA C 601 1555 1555 2.35 LINK OD1 ASP C 172 CA CA C 601 1555 1555 2.58 LINK OG SER C 174 CA CA C 601 1555 1555 2.41 LINK O THR D 168 CA CA D 605 1555 1555 2.44 LINK OG1 THR D 168 CA CA D 605 1555 1555 2.58 LINK O PHE D 170 CA CA D 605 1555 1555 2.31 LINK OD1 ASP D 172 CA CA D 605 1555 1555 2.58 LINK OG SER D 174 CA CA D 605 1555 1555 2.36 CISPEP 1 PRO C 123 PRO C 124 0 9.24 CISPEP 2 GLU C 354 PRO C 355 0 3.16 CISPEP 3 ASN C 549 ASN C 550 0 3.76 CISPEP 4 TYR C 557 PRO C 558 0 4.01 CISPEP 5 PRO D 123 PRO D 124 0 6.55 CISPEP 6 GLU D 354 PRO D 355 0 3.59 CISPEP 7 ASN D 549 ASN D 550 0 3.78 CISPEP 8 TYR D 557 PRO D 558 0 3.36 CRYST1 93.220 63.820 111.340 90.00 97.24 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010727 0.000000 0.001363 0.00000 SCALE2 0.000000 0.015669 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009054 0.00000